Last reviewed · How we verify

NCT04137471: OAS

Validation of the Ontological Addiction Scale

Completed Last updated 25 October 2021
What this trial tests

trial in Mood Disorders in 400 participants. Completed in 31 March 2021.

Timeline
1 November 2019
Primary endpoint
1 March 2021
31 March 2021

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusCompleted
Study typeOBSERVATIONAL
Enrollment400
Start date1 November 2019
Primary completion1 March 2021
Estimated completion31 March 2021
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

Adults 18 to 70, any sex, with Mood Disorders or Emotional Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Bypassing a reductionist view of existing diagnostic categories, ontological addiction theory (OAT) is a new psychological model of human functioning and mental illness. Ontological addiction is a maladaptive condition that stems from an erroneous belief in an inherently existing Self or "I", which is deemed to be the root of all suffering. Five experts from four different countries have created the Ontological Addiction Scale (OAS) to measure the condition and its impact on people's lives. The purpose of this study is to test this scale, evaluating levels of ontological addiction in individuals suffering from emotional or mood disorder, and assess its psychometric properties. Methods: This trial will be conducted in compliance with the COSMIN Guidelines. The investigators will collect data from 400 individuals, aged 18 to 70, suffering from emotional or mood disorder, referred to the Therapeutic Center for Mood and Emotional Disorders for an 8-week-mindfulness-based-intervention. Patients will complete the OAS at three time points: one month before the beginning of the therapy, within one week prior to the beginning of therapy, and one year after the end of the therapy. This scale will be completed in conjunction with other practice assessments relating to the psychotherapeutic program. The psychometric properties of the OAS will be assessed. Discussion: The Investigators aim to validate a scale assessing a psychological dimension as the root of all mental disorders. The present study may contribute to overcoming limitations of categorical understanding of mental disorders, thus moving toward a more encompassing dimensional comprehension. The scale is responsive to current thinking in modern psychiatry, and it is envisaged that its validation will deeply impact research and care perspectives

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. French Translation and Validation of the Ontological Addiction Scale (OAS).
    Ducasse D, Leurent M, Picot MC, Aouinti S, et al · · 2025 · cited 1× · PMID 40283737 · DOI 10.3390/ijerph22040511

Verify or expand the search:

Other recruiting trials for Mood Disorders

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04137471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing